In July and August 2022, as part of the preparations for the initiation of enrolments into CARMA Global, investigators and site staff were oriented on study procedures and the correct sample management techniques
Congratulations to study teams on the acceptance of their abstracts to AIDS 2022
In 2016 the Early-treated Perinatally HIV-infected individuals: Improving Children’s Actual Life (EPIICAL) consortium began gathering scientists and clinicians specialising in paediatric HIV
It takes a community of people working together to achieve the results we are looking for: eradicating HIV in children
The CIPHER Grant Programme directly supports the development of early stage investigators, awarding up to US$150,000 for up to two years to address research gaps in paediatric and adolescent HIV in resource-limited settings.
The CARMA team in the EPIICAL consortium have just published the article Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort) in the Journal of International AIDS Society.
Penta Foundation recently spoke with Paolo Palma of Bambino Gesu Children Hospital in Rome, a core member of the EPIICAL team to uncover some reasons there is still no cure for HIV, even though there is a vaccine for COVID-19, also known as SARS-COV-2 in one year. Continue reading “Paolo Palma speaks on Covid-19 vaccines and the absence of an HIV cure”
The CARMA (Child and Adolescent Reservoir Measurements on early suppressive ART) study team is excited to share that two papers have been accepted for publication into the PLOS Pathogens Journal and the Journal of the International AIDS Society. Continue reading “CARMA study papers to be published in the Journal of the International AIDS Society and PLOS Pathogens Journal”
EPIICAL is proud to have presented four abstracts at the CROI conference this year, sharing updated information on viral decay and the immune response of children living with HIV who begin treatment early in life. Continue reading “Sharing our understanding of the immune response of children living with HIV”
Paolo Palma and his colleagues recently published in The Lancet HIV the paper “The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV“, outlining the reliability of HIV-1-specific antibody concentrations to estimate viral replication and the latent reservoir in patients on long-term ART. Continue reading “EPIICAL in The Lancet: a new strategy to estimate the viral reservoir in HIV-infected children”